Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Weintraub, Neal L ^a   Fang, Xiang ^b   Kaduce, Terry L ^b   VanRollins, Mike ^a   Chatterjee, Papri ^a   Spector, Arthur A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Arachidonic acid; Cytochrome P 450; Dihydroxyeicosatrienoic acids; Porcine coronary artery

Indexed keywords

EPOXIDE HYDROLASE; ICOSATRIENOIC ACID;

ANIMAL EXPERIMENT; ARACHIDONIC ACID METABOLISM; ARTICLE; CORONARY ARTERY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; ICOSANOID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM;

EID: 0032735546     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.5.h2098     Document Type: Article

References (33)

1. Bernstrom, K., K. Kayganich, R. C. Murphy, and F. A. Fitzpatrick. Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J. Biol. Chem. 267: 3686-3690, 1992.
2. Campbell W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423, 1996.
3. Capdevila, J., B. Pramanik, J. L. Napoli, S. Manna, and J. R. Falck. Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver. Arch. Biochem. Biophys. 231: 511-517, 1984.
4. Capdevila, J. H., J. R. Falck, and R. W. Estabrook. Cytochrome P450 and the arachidonate cascade. FASEB J. 6: 731-736, 1992.
5. Chacos, N., J. Capdevila, J. R. Falck, S. Manna, C. Martin-Wixtrom, S. S. Gill, B. D. Hammock, and R. W. Estabrook. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch. Biochem. Biophys. 223: 639-648, 1983.
6. Fang, X., T. L. Kaduce, N. L. Weintraub, M. VanRollins, and A. A. Spector. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ. Res. 79: 784-793, 1996.
7. Fang, X., M. VanRollins, T. L. Kaduce, and A. A. Spector. Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. J. Lipid Res 36: 1236-1246, 1995.
8. Fitzpatrick, F. A., and R. C. Murphy. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol. Rev. 40: 229-241, 1988.
9. Gebremedhin, D., Y.-H. Ma, J. R. Falck, R. J. Roman, M. VanRollins, and D. R. Harder. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H519-H525, 1992.
10. 2+ entry in human and bovine endothelial cells. J. Physiol. (Lond.) 482: 259-274, 1995.
11. Guenther, T. M. Selective inhibition and selective induction of multiple microsomal epoxide hydrolases. Biochem. Pharmacol. 35: 839-845, 1986.
12. Irvine, R. F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 204: 3-16, 1982.
13. Karara, A., E. Dishman, H. Jacobson, J. R. Falck, and J. H. Capdevila. Stereochemical analysis of the endogenous epoxyeicosatrienoic acids of human kidney cortex. FEBS Lett. 268: 227-230, 1990.
14. Karara, A., S. Wei, D. Spady, L. Swift, J. H. Capdevila, and J. R. Falck. Arachidonic acid epoxygenase: structural characteristics and quantification of epoxyeicosatrienoates in plasma. Biochem. Biophys. Res. Commun. 182: 1320-1325, 1992.
15. + channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ. Res. 80: 877-884, 1997.
16. Mullin, C. A., and B. D. Hammock. Chalone oxides - potent and selective inhibitors of cytosolic epoxide hydrolase. Arch. Biochem. Biophys. 216: 423-439, 1982.
17. Oliw, E. H., J. Bylund, and C. Herman. Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450. Lipids 31: 1003-1021, 1996.
18. Pacifici, E. H. K., L. L. McLeod, and A. Sevanian. Lipid hydroperoxide-induced peroxidation and turnover of endothelial cell phospholipids. Free Radic. Biol. Med. 17: 297-309, 1994.
19. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H327-H335, 1993.
20. Rosolowsky, M., and W. B. Campbell. Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine artery endothelial cells. Biochim. Biophys. Acta 1299: 267-277, 1996.
21. Rosolowsky, M., J. R. Falck, J. T. Willerson, and W. B. Campbell. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ. Res. 66: 608-621, 1990.
22. Shivachar, A. C., K. A. Willoughby, and E. F. Ellis. Effect of protein kinase C modulators on 14,15-epoxyeicosatrienoic acid incorporation into astroglial phospholipids. J. Neurochem. 65: 338-346, 1995.
23. Tomoda, H., K. Igarashi, and S. Omura. Inhibition of acyl Co-A synthetase by triacsins. Biochim. Biophys. Acta 921: 595-598, 1987.
24. VanRollins, M., T. L. Kaduce, X. Fang, H. R. Knapp, and A. A. Spector. Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J. Biol. Chem. 271: 14001-14009, 1996.
25. VanRollins, M., T. L. Kaduce, H. R. Knapp, and A. A. Spector. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J. Lipid Res. 34: 1931-1942, 1993.
26. Weintraub, N. L., X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ. Res. 81: 258-267, 1997.
27. Weintraub, N. L., S. N. Joshi, C. A. Branch, A. H. Stephenson, R. S. Sprague, and A. J. Lonigro. Relaxation of porcine coronary artery to bradykinin: role of arachidonic acid. Hypertension 23: 976-981, 1994.
28. Weintraub, N. L., A. H. Stephenson, R. S. Sprague, L. McMurdo, and A. J. Lonigro. Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension 26: 684-690, 1995.
29. Wong, P. Y., P. S. Lai, S. Y. Shen, Y. Y. Belosludtsev, and J. R. Falck. Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J. Lipid Mediat. Cell Signal. 16: 155-169, 1997.
30. Wu, S., C. R. Moomaw, K. B. Tomer, J. R. Falck, and D. C. Zeldin. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in human heart. J. Biol. Chem. 271: 3460-3468, 1996.
31. Zeldin, D. C., J. Kobayashi, J. R. Falck, B. S. Winder, B. D. Hammock, J. R. Snapper, and J. H. Capdevila. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268: 6402-6407, 1993.
32. Zhu, Y., E. B. Schieber, J. C. McGiff, and M. Balazy. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension 25: 854-859, 1995.
33. +-channel activity. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F822-F832, 1996.